These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

839 related items for PubMed ID: 23932319

  • 1. The impact of EGFR mutation status on outcomes in patients with resected stage I non-small cell lung cancers.
    Izar B, Sequist L, Lee M, Muzikansky A, Heist R, Iafrate J, Dias-Santagata D, Mathisen D, Lanuti M.
    Ann Thorac Surg; 2013 Sep; 96(3):962-8. PubMed ID: 23932319
    [Abstract] [Full Text] [Related]

  • 2. Clinical outcomes after first-line EGFR inhibitor treatment for patients with NSCLC, EGFR mutation, and poor performance status.
    Okuma Y, Hosomi Y, Nagamata M, Yamada Y, Sekihara K, Kato K, Hishima T, Okamura T.
    Anticancer Res; 2013 Nov; 33(11):5057-64. PubMed ID: 24222150
    [Abstract] [Full Text] [Related]

  • 3. Risk factor analysis of locoregional recurrence after sublobar resection in patients with clinical stage IA non-small cell lung cancer.
    Koike T, Koike T, Yoshiya K, Tsuchida M, Toyabe S.
    J Thorac Cardiovasc Surg; 2013 Aug; 146(2):372-8. PubMed ID: 23870323
    [Abstract] [Full Text] [Related]

  • 4. Impact of the epidermal growth factor receptor mutation status on the post-recurrence survival of patients with surgically resected non-small-cell lung cancer.
    Takenaka T, Takenoyama M, Yamaguchi M, Toyozawa R, Inamasu E, Kojo M, Toyokawa G, Yoshida T, Shiraishi Y, Morodomi Y, Hirai F, Taguchi K, Shimokawa M, Seto T, Ichinose Y.
    Eur J Cardiothorac Surg; 2015 Mar; 47(3):550-5. PubMed ID: 24894095
    [Abstract] [Full Text] [Related]

  • 5. The presence of mutations in epidermal growth factor receptor gene is not a prognostic factor for long-term outcome after surgical resection of non-small-cell lung cancer.
    Kim YT, Seong YW, Jung YJ, Jeon YK, Park IK, Kang CH, Kim JH.
    J Thorac Oncol; 2013 Feb; 8(2):171-8. PubMed ID: 23287850
    [Abstract] [Full Text] [Related]

  • 6. Clinicopathologic factors affecting the progression-free survival of patients with advanced non-small-cell lung cancer after gefitinib therapy.
    Masago K, Fujita S, Togashi Y, Kim YH, Hatachi Y, Fukuhara A, Nagai H, Sakamori Y, Mio T, Mishima M.
    Clin Lung Cancer; 2011 Jan; 12(1):56-61. PubMed ID: 21273181
    [Abstract] [Full Text] [Related]

  • 7. Prognostic factors after complete resection of pN2 non-small cell lung cancer.
    Sonobe M, Date H, Wada H, Okubo K, Hamakawa H, Teramukai S, Matsumura A, Nakagawa T, Sumitomo S, Miyamoto Y, Okumura N, Takeo S, Kawakami K, Aoki M, Kosaka S, The Japan-Multinational Trial Organization.
    J Thorac Cardiovasc Surg; 2013 Oct; 146(4):788-95. PubMed ID: 23810113
    [Abstract] [Full Text] [Related]

  • 8. Epidermal growth factor receptor mutation is associated with longer local control after definitive chemoradiotherapy in patients with stage III nonsquamous non-small-cell lung cancer.
    Yagishita S, Horinouchi H, Katsui Taniyama T, Nakamichi S, Kitazono S, Mizugaki H, Kanda S, Fujiwara Y, Nokihara H, Yamamoto N, Sumi M, Shiraishi K, Kohno T, Furuta K, Tsuta K, Tamura T.
    Int J Radiat Oncol Biol Phys; 2015 Jan 01; 91(1):140-8. PubMed ID: 25442336
    [Abstract] [Full Text] [Related]

  • 9. High expression of the transcriptional co-activator p300 predicts poor survival in resectable non-small cell lung cancers.
    Hou X, Li Y, Luo RZ, Fu JH, He JH, Zhang LJ, Yang HX.
    Eur J Surg Oncol; 2012 Jun 01; 38(6):523-30. PubMed ID: 22440742
    [Abstract] [Full Text] [Related]

  • 10. Clinical and molecular predictors of recurrence in stage I non-small cell lung cancer.
    Starnes SL, Pathrose P, Wang J, Succop P, Morris JC, Bridges J, Kupert EY, Anderson M.
    Ann Thorac Surg; 2012 May 01; 93(5):1606-12. PubMed ID: 22440368
    [Abstract] [Full Text] [Related]

  • 11. The survival outcomes of patients with resected non-small cell lung cancer differ according to EGFR mutations and the P21 expression.
    Na II, Rho JK, Choi YJ, Kim CH, Park JH, Koh JS, Ryoo BY, Yang SH, Lee JC.
    Lung Cancer; 2007 Jul 01; 57(1):96-102. PubMed ID: 17337084
    [Abstract] [Full Text] [Related]

  • 12. ERCC1 expression by immunohistochemistry and EGFR mutations in resected non-small cell lung cancer.
    Lee KH, Min HS, Han SW, Oh DY, Lee SH, Kim DW, Im SA, Chung DH, Kim YT, Kim TY, Heo DS, Bang YJ, Sung SW, Kim JH.
    Lung Cancer; 2008 Jun 01; 60(3):401-7. PubMed ID: 18036700
    [Abstract] [Full Text] [Related]

  • 13. Epidermal growth factor receptor mutation status and adjuvant chemotherapy in resected advanced non-small-cell lung cancer.
    Sun HB, Ou W, Li Y, Fang Q, Qin J, Zhang L, Wang SY.
    Clin Lung Cancer; 2013 Jul 01; 14(4):376-82. PubMed ID: 23291256
    [Abstract] [Full Text] [Related]

  • 14. EGFR and TTF-1 gene amplification in surgically resected lung adenocarcinomas: clinicopathologic significance and effect on response to EGFR-tyrosine kinase inhibitors in recurred cases.
    Lee JS, Kim HR, Lee CY, Shin M, Shim HS.
    Ann Surg Oncol; 2013 Sep 01; 20(9):3015-22. PubMed ID: 23525704
    [Abstract] [Full Text] [Related]

  • 15. Epidermal growth factor receptor mutations in female patients with postoperative recurrent non-small-cell lung cancer.
    Na II, Kim HR, Lee JK, Park SH, Kim CH, Koh JS, Baek HJ, Choe du H.
    J Cancer Res Ther; 2012 Sep 01; 8(3):373-8. PubMed ID: 23174717
    [Abstract] [Full Text] [Related]

  • 16. Epidermal growth factor receptor mutation and treatment outcome of mediastinoscopic N2 positive non-small cell lung cancer patients treated with neoadjuvant chemoradiotherapy followed by surgery.
    Ahn HK, Choi YL, Han JH, Ahn YC, Kim K, Kim J, Shim YM, Um SW, Kim H, Kwon OJ, Sun JM, Ahn JS, Park K, Ahn MJ.
    Lung Cancer; 2013 Mar 01; 79(3):300-6. PubMed ID: 23261144
    [Abstract] [Full Text] [Related]

  • 17. Prognostic factors for gefitinib-treated postoperative recurrence in non-small cell lung cancer.
    Okami J, Taniguchi K, Higashiyama M, Maeda J, Oda K, Orita N, Koizumi K, Kodama K, Kato K.
    Oncology; 2007 Mar 01; 72(3-4):234-42. PubMed ID: 18176089
    [Abstract] [Full Text] [Related]

  • 18. The prognostic impact of microRNA sequence polymorphisms on the recurrence of patients with completely resected non-small cell lung cancer.
    Yoon KA, Yoon H, Park S, Jang HJ, Zo JI, Lee HS, Lee JS.
    J Thorac Cardiovasc Surg; 2012 Oct 01; 144(4):794-807. PubMed ID: 22818121
    [Abstract] [Full Text] [Related]

  • 19. Role of EGFR SNPs in survival of advanced lung adenocarcinoma patients treated with Gefitinib.
    Zhang L, Yuan X, Chen Y, Du XJ, Yu S, Yang M.
    Gene; 2013 Mar 15; 517(1):60-4. PubMed ID: 23313300
    [Abstract] [Full Text] [Related]

  • 20. Induction therapy followed by surgery for T3-T4/N0 non-small cell lung cancer: long-term results.
    Lococo F, Cesario A, Margaritora S, Dall'Armi V, Nachira D, Cusumano G, Meacci E, Granone P.
    Ann Thorac Surg; 2012 May 15; 93(5):1633-40. PubMed ID: 22480394
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 42.